BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1191 related articles for article (PubMed ID: 19019453)

  • 1. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.
    Kleindienst N; Severus WE; Greil W
    Int Clin Psychopharmacol; 2007 May; 22(3):125-31. PubMed ID: 17414737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsants in bipolar disorder.
    Singh V; Muzina DJ; Calabrese JR
    Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
    Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
    Nolen WA; Weisler RH
    Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
    Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W
    Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
    Singh V; Bowden CL; Mintz J
    Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
    Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
    Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
    Franks M; Macritchie KA; Mahmood T; Young AH
    J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder.
    Waters B; Lapierre Y; Gagnon A; Cahudhry R; Tremblay A; Sarantidis D; Gray R
    Biol Psychiatry; 1982 Nov; 17(11):1323-9. PubMed ID: 6817830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring of lithium in patients with bipolar affective disorder: experiences from a tertiary care hospital in India.
    Sharma S; Joshi S; Chadda RK
    Am J Ther; 2009; 16(5):393-7. PubMed ID: 19262359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
    Tondo L; Baldessarini RJ; Floris G
    Br J Psychiatry Suppl; 2001 Jun; 41():s184-90. PubMed ID: 11450181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
    Yoshimura R; Ueda N; Shinkai K; Nakamura J
    Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prediction of treatment response in acute mania: controlled clinical trials with divalproex].
    Swann AC
    Encephale; 2001; 27(3):277-9. PubMed ID: 11488258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium maintenance: factors affecting outcome.
    Kocsis JH; Stokes PE
    Am J Psychiatry; 1979 Apr; 136(4B):563-6. PubMed ID: 426144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.